Related Experiment Video
Updated: Jun 21, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Adenosine for wide-complex tachycardia: efficacy and safety
Keith A Marill1, Sigrid Wolfram, Ian S Desouza
1Department of Emergency Medicine (KAM), Massachusetts General Hospital, Boston, MA, USA. kmarill@partners.org
Adenosine effectively diagnoses and treats wide QRS complex tachycardia. This study found it safe and useful for identifying supraventricular tachycardia versus ventricular tachycardia.
Area of Science:
- Cardiology
- Electrophysiology
- Emergency Medicine
Background:
- The etiology of sustained monomorphic wide QRS complex tachycardia is often uncertain.
- Accurate diagnosis is crucial for appropriate management.
Purpose of the Study:
- To evaluate the diagnostic and therapeutic utility of adenosine in patients with undifferentiated wide QRS complex tachycardia.
- To assess the safety profile of adenosine in this patient population.
Main Methods:
- Retrospective observational study of 197 patients treated with adenosine for regular wide QRS complex tachycardia.
- Analysis of rhythm response to adenosine and adverse events.
- Determination of adenosine's accuracy in differentiating supraventricular tachycardia from ventricular tachycardia.
Main Results:
- Adenosine demonstrated a high response rate: 90% for supraventricular tachycardia and 2% for ventricular tachycardia.
- A positive response significantly increased the odds of supraventricular tachycardia (36-fold).
- No primary adverse events were observed in either supraventricular tachycardia or ventricular tachycardia groups.
Conclusions:
- Adenosine is a safe and effective diagnostic tool for wide QRS complex tachycardia.
- Adenosine aids in differentiating supraventricular tachycardia from ventricular tachycardia, guiding therapeutic decisions.
More Related Videos
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure Drugs: Inotropic Agents